Nouveauté
Cognitive-Behavioral Therapy for Posttraumatic Stress Disorder
Par :Formats :
Disponible dans votre compte client Decitre ou Furet du Nord dès validation de votre commande. Le format ePub est :
- Compatible avec une lecture sur My Vivlio (smartphone, tablette, ordinateur)
- Compatible avec une lecture sur liseuses Vivlio
- Pour les liseuses autres que Vivlio, vous devez utiliser le logiciel Adobe Digital Edition. Non compatible avec la lecture sur les liseuses Kindle, Remarkable et Sony
, qui est-ce ?Notre partenaire de plateforme de lecture numérique où vous retrouverez l'ensemble de vos ebooks gratuitement
Pour en savoir plus sur nos ebooks, consultez notre aide en ligne ici
- FormatePub
- ISBN8235242289
- EAN9798235242289
- Date de parution17/07/2026
- Protection num.pas de protection
- Infos supplémentairesepub
- ÉditeurIoakim Ioakim
Résumé
Posttraumatic stress disorder (PTSD) can develop after exposure to a traumatic event and impacts roughly 5-8% of trauma-exposed individuals. Individuals with PTSD develop distressing intrusions, trauma-related avoidance, alterations in mood and cognition, and hyperarousal. There are both social and neurobiological factors that appear to confer risk for PTSD. There are high rates of psychiatric comorbidity, particularly with respect to mood disorders and substance use disorders.
PTSD is associated with significant functional impairment and is likely to persist when untreated. Cognitive-behavioral psychotherapies, specifically prolonged exposure and cognitive processing therapy, have the most research supporting their use as frontline treatments for PTSD. Although effect sizes are not as robust as with psychotherapy, some of the selective serotonin reuptake inhibitors (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medications are associated with benefits.
Psychological debriefing methods are not recommended for the treatment of PTSD. With successful treatment, PTSD can remit, and individuals return to their premorbid level of functioning.
PTSD is associated with significant functional impairment and is likely to persist when untreated. Cognitive-behavioral psychotherapies, specifically prolonged exposure and cognitive processing therapy, have the most research supporting their use as frontline treatments for PTSD. Although effect sizes are not as robust as with psychotherapy, some of the selective serotonin reuptake inhibitors (SSRI) and serotonin-norepinephrine reuptake inhibitor (SNRI) medications are associated with benefits.
Psychological debriefing methods are not recommended for the treatment of PTSD. With successful treatment, PTSD can remit, and individuals return to their premorbid level of functioning.







